New roles at Vertex amid Crinetics integration

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is shuffling its C-suite as it integrates Crinetics Pharmaceuticals Inc., following Tuesday’s close of that $10 billion acquisition.

As COO Charles Wagner leads the integration process in an expanded role, he will hand off his other title of CFO to Jonathan Poole, who will be promoted to EVP and CFO...